Technological innovations are driving a transition in the pharmaceutical industry and a new focus on adherence is occurring in the consumer-driven medical device industry. Medical devices are seen as a way to improve both patient…

Patient support programs (PSP) available for pharmaceutical/biotechnology products or therapeutic areas have unique features and benefits. While there are notable differences across programs, there are some common elements found…

After decades of R&D, numerous lessons learned, and limited initial adoption, gene therapy has finally become a clinically and financially viable option for certain indications globally. In the early 2000’s, gene therapy was…

The global market for new and innovative drug delivery systems remains strong and manufacturers will continue to face significant competition as they select devices for their drugs. Over half of all disclosed treatments across a broad…

As expected, biosimilars news made top headlines right out of the starting gate in 2015, with Novartis’s biosimilars version of filgrastim gaining a 14-0 positive vote by the FDA’s independent Oncologic Drugs Advisory Committee on…